Jump Financial’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.01M Buy
157,000
+115,625
+279% +$3.83M 0.04% 516
2026
Q1
$1.58M Buy
+41,375
New +$1.34M 0.02% 751
2025
Q4
Sell
-62,000
Closed -$867K 2314
2025
Q3
$867K Sell
62,000
-9,119
-13% -$104K 0.01% 1080
2025
Q2
$681K Buy
71,119
+43,170
+154% +$410K 0.01% 1124
2025
Q1
$260K Buy
27,949
+12,789
+84% +$165K ﹤0.01% 1347
2024
Q4
$211K Buy
+15,160
New +$275K ﹤0.01% 1464
2024
Q3
Sell
-12,754
Closed -$204K 2135
2024
Q2
$204K Sell
12,754
-2,405
-16% -$41.4K ﹤0.01% 1558
2024
Q1
$249K Buy
+15,159
New +$249K 0.01% 1547

Other funds holding TYRA

Jump Financial's TYRA Position: Q2 2026 in Review

Jump Financial increased its Tyra Biosciences (TYRA) stake by 279% in Q2 2026, buying an estimated $3.83M and bringing the position to 157,000 shares worth $5.01M. The position accounts for 0.04% of the portfolio, ranked #516.

Jump Financial first reported a position in TYRA in Q1 2024 and has held it in 8 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Jump Financial held 157,000 shares of Tyra Biosciences worth $5.01M as of Q2 2026.
  • Jump Financial bought 115,625 Tyra Biosciences shares in Q2 2026, an estimated $3.83M.
  • Tyra Biosciences made up 0.04% of Jump Financial's portfolio in Q2 2026, its #516 holding.
  • Jump Financial first reported a position in Tyra Biosciences in Q1 2024 and has held it in 8 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.